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【論文審査】Review of the thesis
Magneticnanoparticleshavegarneredalotofattentioninbiomedicalandindustrialappli-
cationsowingtotheirbiocompatibility,easeofbiofunctionalizationanditsinherentmag-




















geted chemotherapy, imaging, and hyperthermia against cancer. A multifunctional












and encapsulated with potent anticancerous drug. The biocompatibility of EPS coated
MNPsandsynergisticeffectofmagnetichyperthermiaanddrugforenhancedantiprolifera-





In the 5th chapter, Mr. Siva discusses the synthesis of curcumin encapsulated PLGA-
magnetic nanoparticles and their augmented cellular uptake and antiproliferation against





cumin, a natural antitumor agent, encapsulated in PLGA nanoparticles (Cur-SPION-
PLGA-NPs) against pancreatic cancer cells was investigated. Specificity to the
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nanoconjugate was imparted by conjugating HER2 to Cur-SPION-PLGA that confirmed











nanoparticles, functionalized with two targeting ligands specific towards cancer are dis-
cussedinthework.Thismultifunctional,highlyspecificnanoconjugateresultedinsuperior
uptakeofnanoparticlesbycancercells.Byusingmagnetichyperthermia;duetotheadded








a promising approach to selectively deliver therapeutics and image them in cancer cells.
Thisstudyexploredthepreparation,characterizationandapplicationofatargetednano-
system represented by aptamer conjugated dual drug (Curcumin andGemcitabine-loaded)
andMNPencapsulatedPLGAnanoparticles (Apt-Cur-Gem-PLGA-MNPs) forpancreatic
cancer therapy. The aptamer targeted NPs exhibited excellent antiproliferative activity
leadingtoapoptosisowingtoenhancedcellularuptake.ThepresenceofMNPinnanoconju-








attaching three specific targeting ligands (folate, transferrin and AS1411 aptamer). He




【審査結果】 Summary and decision
The thesis entitled“Multifunctional biocompatiblemagnetic nanoparticles as theragnostic
agents: applications in cancer nanotechnology” focuses on the synthesis of theragnostic
agents(TherapyandDiagnosis)bycouplingmagneticnanoparticles,drugsandimagingmoi-




• A multifunctional biocompatible nanovector based on magnetic nanoparticle and car-
boxymethylcellulose(CMC)hasbeendemonstrated.Theresultsindicatethatthemulti-
functionalCMCMNPspossessahighdrugloadingefficiencyandhighbiocompatibility
and with low cell cytotoxicity and can be considered to be promising candidates for
CMC-basedtargeteddrugdelivery,cellularimaging,andmagnetichyperthermia(MHT).
• MauranandGellangumcoatedMNPsexhibitedexcellentbiocompatibilitywithlowcell
cytotoxicity, high therapeutic potential, and superparamagnetic behavior that can be
employed as prospective candidates for bacterial EPS based targeted drug delivery,
cancercellimagingandformagnetichyperthermia(MHT)forkillingcancercellswithin
shortperiodoftime.
• HER2-Cur-SPION-PLGA demonstrated greater and sustained therapeutic efficiency,
however, upon exposure to external magnetic field; the anti-proliferative activity of
HER2-Cur-SPION-PLGA was augmented owing to superior cellular uptake that
resultedinenhancedcytotoxicity.Invitroresultssupportpotentialclinicalapplications
of HER2-Cur-SPION-PLGA NPs by activating the loss of mitochondrial membrane
potentialtherebytriggeringapoptosisincancercells.
• Aptamer conjugated dual drug (Curcumin and Gemcitabine-loaded) and MNP
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by rotational magnetic field. Thus, Apt-Cur-Gem-PLGA-MNPs is able to deliver an
effectualandtargeteddeliveryoftherapeuticsforpancreaticcancertreatment.
Based on the work, 2 first-authoring and 1 co-authoring papers have been published in
internationaljournalssuchasLangmuirandInternational Journal of Nanomedicine.
Judgingbytheresultsshowninthethesisandthenumberofinternationalpaperspublished
sofar,thelevelofthepresentresearchresultsisdefinitelyhighbyinternationalstandards
andthepresentresultsmaywellmakeagreatcontributiontothenanodrugdeliveryagainst
cancer.Inconclusion,thethesisisconsideredasahighquality,highstandardonebyinter-
nationalstandards.
